Overview

Special Drug Use Investigation of EYLEA for Diabetic Macular Edema

Status:
Completed
Trial end date:
2019-08-13
Target enrollment:
Participant gender:
Summary
The objectives of this study are to investigate the safety and effectiveness of EYLEA
Details
Lead Sponsor:
Bayer
Collaborator:
Regeneron Pharmaceuticals
Treatments:
Aflibercept